{"slideshow_credits": null, "snippet": "The drug maker Allergan said the Food and Drug Administration had declined to approve Levadex because of concerns about the manufacturing of the inhaler used with it.", "abstract": null, "section_name": "Business Day", "print_page": "", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/04/17/business/fda-rejects-levadex-a-new-drug-for-migraines.html", "lead_paragraph": "The drug maker Allergan said the Food and Drug Administration had declined to approve Levadex because of concerns about the manufacturing of the inhaler used with it.", "headline": {"seo": "F.D.A. Rejects Levadex, a New Drug for Migraines", "main": "F.D.A. Rejects New Drug for Migraines", "print_headline": "F.D.A. Rejects New Drug for Migraines"}, "_id": "516dab3ecf28d02a61000dd1", "word_count": "432", "multimedia": [], "pub_date": "2013-04-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Migraine Headaches", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "News"}